Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage-Reference-Cited by-同舟云学术

Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage

Published:2017-02-01 Issue:2 Volume:74 Page:173
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Renoux Christel¹,Vahey Sarah²,Dell’Aniello Sophie²,Boivin Jean-François³

Affiliation:

1. Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada2Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada3Department of Epidemiology and Biostatistics, McGill University, Montréal, Québec, Canada

2. Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada

3. Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada3Department of Epidemiology and Biostatistics, McGill University, Montréal, Québec, Canada

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the correlation between cardiovascular adverse events and antidepressant use: A retrospective pharmacovigilance analysis based on the FDA Adverse Event Reporting System database;Journal of Affective Disorders;2024-12

2. Die Bedeutung der Kombination von Pharmakodynamik und Pharmakoepidemiologie für das Verständnis und die Verbesserung der Arzneimittelsicherheit;Nervenheilkunde;2024-08

3. Traditional Chinese medicine for male sexual dysfunction and the risk of major adverse cardiovascular events: A population-based retrospective cohort study;2024-07-15

4. Feeling blue to seeing red: A case of escitalopram‐induced epistaxis;Clinical Case Reports;2024-07

5. Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors;Journal of Affective Disorders;2024-04